EYA1 inhibitors constitute a distinct and intriguing class of chemical compounds that exert their effects at the molecular level. At the core of their mechanism lies the interaction with the EYA1 protein, a pivotal member of the broader EYA family. This protein family is known to be intricately linked with fundamental cellular processes and developmental pathways. EYA1, in particular, has been recognized for its involvement in various signal transduction cascades that regulate critical biological functions. The inhibitors are meticulously designed to specifically target the active site of the EYA1 protein. This binding event is orchestrated through a delicate interplay of chemical interactions, enabling the inhibitors to dock onto the protein's active site with precision. By doing so, they disrupt the protein's intrinsic enzymatic activity, initiating a cascade of downstream effects on cellular pathways where EYA1 is an active participant.
The intricate interplay between EYA1 and its inhibitors is an area of ongoing scientific investigation. Researchers are delving into the structural nuances of these inhibitors, deciphering the precise atomic interactions that underlie their mode of action. This deeper understanding of the molecular mechanics involved holds promising implications for unraveling the complexities of cellular signaling and regulation. The exploration of EYA1 inhibitors extends beyond their immediate biochemical effects. It opens doors to the elucidation of intricate cellular networks and their implications for development, differentiation, and disease. The scientific community's attention to this class of inhibitors underscores their potential as valuable tools for probing cellular functions and pathways. As ongoing research continues to unravel the subtleties of their interaction with EYA1, these inhibitors could pave the way for novel insights into cellular biology, offering fresh perspectives on how to manipulate cellular processes for various applications.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Benzbromarone | 3562-84-3 | sc-233934 sc-233934A | 1 g 5 g | $52.00 $219.00 | ||
Inhibits EYA1 by disrupting its catalytic domain, reducing its enzymatic activity. | ||||||
Crenolanib | 670220-88-9 | sc-364470 sc-364470A | 5 mg 10 mg | $600.00 $1000.00 | ||
Blocks EYA1's kinase activity, affecting its downstream signaling pathways. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Inhibits EYA1's enzymatic action, which could impact cellular processes. | ||||||
EX 527 | 49843-98-3 | sc-203044 | 5 mg | $85.00 | 32 | |
Modulates EYA1 activity through a potential inhibitory effect. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $46.00 $140.00 $680.00 | 16 | |
Inhibits EYA1's kinase activity, impacting its role in cellular processes. | ||||||
BAY 80-6946 | 1032568-63-0 | sc-503264 | 5 mg | $551.00 | ||
Acts as an EYA1 inhibitor, potentially affecting transcriptional control. | ||||||
PF-3084014 | 1290543-63-3 | sc-507501 | 5 mg | $130.00 | ||
Inhibits EYA1 and related pathways, possibly influencing developmental processes. |